FDA Approves Stemedica Phase II Clinical Trial For Acute Myocardial…
Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that the U.S. Food and Drug Administration (FDA) approved its…(PRWeb October 02, 2012)Read the full story at http://…
FDA Approves Stemedica Phase II Clinical Trial For Acute Myocardial… Read Post »